Skin disorder therapeutic - Actio Biosciences
Latest Information Update: 22 Sep 2023
At a glance
- Originator Actio Biosciences
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Skin disorders